Object. L6 cells were cultured to explore the possible mechanism underlying the improvement of insulin resistance by Liraglutide (LR). Methods. Cells were divided into 5 groups—control, high-fat, 10 nmol/L
LR
+
0.6
mmol/L palmitic acid (PA) (10LR), 100 nmol/L
LR
+
0.6
mmol/L PA (100LR), and 1000 nmol/L
LR
+
0.6
mmol/L PA (1000LR). CCK-8 method to detect cell viability, GPO-PAP enzymatic method to detect intracellular triglyceride content, and reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) and western blotting methods to detect fatty acid translocase CD36 (FAT/CD36) and fatty acid binding protein 4 (FABP4) in L6 cells, glucose-regulated protein 78 (GRP78), glucose transporter 4 (GLUT4) expression at the mRNA and protein levels, respectively, were performed. Results. We found that after PA intervention for 24 h, the cell viability decreased significantly; the cell viability of the LR group was higher than that of the high-fat group (
P
<
0.01
). After PA intervention, compared with those in the high-fat group, GRP-78, FAT/CD36, FABP4 mRNA ((4.36 ± 0.32 vs.
8.15
±
0.35
); (
1.00
±
0.04
vs.
2.46
±
0.08
); (
2.88
±
0.55
vs.
8.29
±
0.52
),
P
<
0.01
) and protein ((
3338.13
±
333.15
vs.
4963.98
±
277.29
); (
1978.85
±
124.24
vs.
2676.07
±
100.64
); (
3372.00
±
219.84
vs.
6083.20
±
284.70
), both
P
<
0.01
) expression decreased in the LR group. The expression levels of GLUT4 mRNA ((
0.75
±
0.04
vs.
0.34
±
0.03
),
P
<
0.01
) and protein ((
3443.71
±
191.89
vs.
2137.79
±
118.75
),
P
<
0.01
) increased. Conclusion. Therefore, we conclude that LR can reverse PA-induced cell inactivation and lipid deposition, which may be related to the change in GRP-78, FAT/CD36, FABP4, GLUT4, and other factors.